In this study, we investigated the effects of silencing NF-κB1, ANGPTL4 and Notch1 genes in combination with gemcitabine on the viability of pancreatic cancer cell line (PANC-1) in vitro. This evidence concerns the gene NFKB1 and pancreatic neoplasm.